Image (Daf3de4f C060 46ef 91c9 7c4137cfe712 01)
Miglustat Capsule
Product Images NDC 68475-204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 68475-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Blister Label (Daf3de4f C060 46ef 91c9 7c4137cfe712 02)
This information provides details about migLUstat Capsules in 100mg strength, manufactured by Navets LLC. The text also mentions Marvacurato Mo 4G and includes manufacturing information for Navnia L, as well as Navea LG.*
Carton Label (Daf3de4f C060 46ef 91c9 7c4137cfe712 03)
This text is a label for MigLUstat Capsules containing 100mg per capsule. The package is not child-resistant and contains 90 capsules in six blister cards. The active ingredient is 100mg of gUstatpo apsie, and the inactive ingredients include magposium seaal, povidore, and sodium sarch gy. Storage instructions recommend storing between 15°C and 30°C. Dosage details are recommended to be obtained from the prescription information. Be sure to keep MigLUstat and all medicines out of reach of children. The manufacturer is Navinta LLC located at 1499 Lowe Retry Road, Ewing, NJ 08818, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
